CHEOF vs ABT: Which Stock is Better?
Side-by-side comparison of Cochlear Limited and Abbott Laboratories in 2026
CHEOF
Cochlear Limited
$125.00
ABT
Abbott Laboratories
$96.81
Key Metrics Comparison
| Metric | CHEOF | ABT | Winner |
|---|---|---|---|
| Market Cap | $11.64B | $168.23B | ABT |
| P/E Ratio | 47.34 | 26.74 | ABT |
| EPS (TTM) | $3.76 | $3.62 | CHEOF |
| Revenue Growth | -0.0% | 0.1% | ABT |
| Gross Margin | 72.8% | 56.5% | CHEOF |
Analyze CHEOF
Full quant analysis
Analyze ABT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHEOF or ABT a better investment?
Comparing CHEOF and ABT: Cochlear Limited has a market cap of $11.64B while Abbott Laboratories has $168.23B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHEOF and ABT?
CHEOF (Cochlear Limited) and ABT (Abbott Laboratories) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHEOF or ABT?
Based on P/E ratios, ABT trades at a lower multiple (26.7x vs 47.3x).
Which is growing faster: CHEOF or ABT?
ABT has higher revenue growth at 0.1% vs -0.0% for CHEOF.
Which company is more profitable: CHEOF or ABT?
Cochlear Limited (CHEOF) has higher gross margins at 72.8% compared to 56.5% for ABT.
Which is the larger company: CHEOF or ABT?
Abbott Laboratories (ABT) is larger with a market cap of $168.23B compared to $11.64B for CHEOF.
Should I buy CHEOF or ABT in 2026?
Both CHEOF and ABT have investment merit. CHEOF trades at $125.00 while ABT trades at $96.81. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHEOF and ABT stock?
Key differences: Market Cap ($11.64B vs $168.23B), P/E Ratio (47.3x vs 26.7x), Revenue Growth (-0.0% vs 0.1%), Gross Margin (72.8% vs 56.5%).